medigraphic.com

2015, Number S2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S2)

General aspects of structure, classification and replication of human papillomavirus

Santos-López G, Márquez-Domínguez L, Reyes-Leyva J, Vallejo-Ruiz V

Language: Spanish
References: 30
Page: 166-171
PDF size: 334.88 Kb.


ABSTRACT

Human papillomavirus (HPV) refers to a group of viruses which belongs to a larger group, commonly referred to as papillomaviruses. These viruses are taxonomically located in the Papillomaviridae family. Papillomaviruses are small, non-enveloped with a genome of double-stranded DNA and they have affinity for epithelial tissue. Many of them are associated with human infection; they induce benign lesions of the skin (warts) and mucous membranes (condylomas), but they are also associated with some epithelial malignancies, such as cervical cancer and other tumors of the urogenital tract. Papillomaviridae contains 16 genera, which are named with a Greek letter prefix and the termination papillomavirus, e.g., Alphapapillomavirus, Betapapillomavirus, etcetera. From the clinical point of view, human papillomaviruses infecting the genital tract (which are located in the genus Alphapapilomavirus) have been divided into two groups: those of low risk, associated with benign genital warts, and those of high risk, with oncogenic potential, which are the etiological agents of cervical cancer. In this paper we review some relevant aspects of the structure, replication cycle and classification of human papillomaviruses.


REFERENCES

  1. Howley PM, Lowy DR. Papillomaviruses. In: Knipe DM, Howly PM, editors. Fields Virology. Philadelphia, USA: Lippincott Williams & Wilkins; 2007. p. 2299-354.

  2. Lizano M, Berumen J, Garcia-Carranca A. HPVrelated carcinogenesis: basic concepts, viral types and variants. Arch Med Res. 2009;40(6):428-34.

  3. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-75.

  4. Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;384(2):260-5.

  5. Sarid R, Gao SJ. Viruses and human cancer: from detection to causality. Cancer Lett. 2011;305(2):218-27.

  6. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401(1):70-9.

  7. Belnap DM, Olson NH, Cladel NM, Newcomb WW, Brown JC, Kreider JW, et al. Conserved features in papillomavirus and polyomavirus capsids. J Mol Biol. 1996;259(2):249-63.

  8. Bernard HU, Burk RD, de Villiers EM, zur Hausen H. Family - Papillomaviridae. Virus Taxonomy. San Diego: Elsevier; 2011. p. 235-48.

  9. Garcea RL, Chen XS. Papillomavirus Structure and Assembly. In: Garcea RL, Di Maio D, editors. The Papillomaviruses. New York, USA: Springer; 2007.

  10. Hiller T, Iftner T. The human papillomavirus. In: Prendiville W, Davies P, editors. HPV Handbook. London, U.K.: Taylor & Francis Group; 2004. p. 11-26.

  11. Conway MJ, Meyers C. Replication and assembly of human papillomaviruses. J Dent Res. 2009;88(4):307-17.

  12. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30 (Suppl 5):F55-70.

  13. Semba M, Mori N. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Rev. 2012;6:e17. doi: 10.4081/oncol.2012.e17. eCollection 2012.

  14. De Witte L, Zoughlami Y, Aengeneyndt B, David G, van Kooyk Y, Gissmann L, et al. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation. Immunobiology. 2007;212(9-10):679-91.

  15. Knappe M, Bodevin S, Selinka HC, Spillmann D, Streeck RE, Chen XS, et al. Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J Biol Chem. 2007;282(38):27913-22.

  16. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol. 1997;71(3):2449-56.

  17. Fothergill T, McMillan NA. Papillomavirus viruslike particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology. 2006;352(2):319-28.

  18. Fernandes JV, Fernandes TAAM. Human papillomavirus: biology and pathogenesis. In: Broek DV, editor. Human papillomavirus and related diseases from Bench to Bedside a clinical perspective. Rijeka, Croatia: InTech; 2012. p. 3-40.

  19. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550-60.

  20. Leto M, Santos Junior GF, Porro AM, Tomimori J. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol. 2011;86(2):306-17.

  21. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004;64(11):3878-84.

  22. Van Doorslaer K, Bernard HU, Chen Z, de Villiers EM, zur Hausen H, Burk RD. Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature. Trends Microbiol. 2011;19(2):49-50; author reply 50-1.

  23. Picconi MA, Alonio LV, Garcia Carranca A, Lizano M, Cervantes Vazquez G, Distefano AL, et al. [Molecular variants of human papillomavirus (HPV) types 16 and 18 in adenocarcinomas of the cervix]. Medicina (B Aires). 2000;60(6):889-94.

  24. De Villiers EM. Cross-roads in the classification of papillomaviruses. Virology. 2013. 445(1-2):2-10. doi: 10.1016/j.virol.2013.04.023. Epub 2013 May 16.

  25. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17-27.

  26. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27.

  27. Crow JM. HPV: The global burden. Nature. 2012;488(7413):S2-3.

  28. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993;67(11):6424-31.

  29. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995;69(12):7743-53.

  30. Burk RD, Chen Z, Harari A, Smith BC, Kocjan BJ, Maver PJ, et al. Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Panonica Adriat. 2011;20(3):113-23.




2020     |     www.medigraphic.com